Four (33%) symptomatic cases reported receiving medical care outside of a medical provider at an isolation facility. The most commonly reported symptoms day 30 + were fatigue (27%) and rhinorrhea (27%), with 8 (36%) reporting symptoms that interfered with or prevented daily activities. While five (23%) cases reported ≥ 1 symptom at baseline, this increased to 77% (10/13) between day 30–59 and 33% (4/12) day 90 + . Of 53 eligible COVID-19 cases, 22 (42%) completed ≥ 1 follow-up survey. To assess the impact of COVID-19 on the risk of symptom presence at follow-up (day 30–225 post-enrollment test), we performed log-linear regression with robust standard errors, adjusting for confounding by shelter site and demographic variables determined a priori. Among controls, 22 were positive and 22 were negative for one of 27 other respiratory virus pathogens. We included a subset of 22 COVID-19-positive cases who tested positive or inconclusive for SARS-CoV-2 and 44 COVID-19-negative controls who tested negative for SARS-CoV-2, frequency matched on age and sex. Adults ≥ 18 years, residing across nine homeless shelters with active respiratory virus surveillance, were eligible to complete in-person baseline surveys and interval follow-up phone surveys.
We conducted a matched prospective cohort study to assess the prevalence, characteristics, and impact of long COVID among sheltered PEH in Seattle, WA between September 2020-April 2022. People experiencing homelessness (PEH) are at increased risk for acquiring SARS-CoV-2, but the burden of long COVID in this population is unknown.
0 kommentar(er)
